Published in J Pathol on February 01, 1998
Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol (2000) 2.99
Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am J Gastroenterol (2001) 2.21
Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol (2001) 2.17
Rapid quantitative assessment of gastric corpus atrophy in tissue sections. J Clin Pathol (2001) 1.50
Barrett's oesophagus and proton pump inhibitors: a pathological perspective. Gut (2000) 1.17
Report of an Amsterdam working group on Barrett esophagus. Virchows Arch (2003) 1.08
ACP. Best Practice No 155. Guidelines for handling oesophageal biopsies and resection specimens and their reporting. J Clin Pathol (2000) 1.03
Routine morphometrical analysis can improve reproducibility of dysplasia grade in Barrett's oesophagus surveillance biopsies. J Clin Pathol (2002) 0.90
Advances in cancer tissue microarray technology: Towards improved understanding and diagnostics. Anal Chim Acta (2006) 0.85
[Subjective grading of Barrett's neoplasia by pathologists: correlation with objective histomorphometric variables]. Pathologe (2013) 0.75
Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst (2000) 16.92
Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet (1995) 7.64
Extended lymph-node dissection for gastric cancer. N Engl J Med (1999) 7.43
Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol (2004) 6.47
Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol (2001) 6.30
Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med (1993) 6.13
Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group. Lancet (2000) 5.31
Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med (1987) 4.55
Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg (2000) 3.83
Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet (1994) 3.69
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol (1993) 3.56
Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol (2007) 3.53
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res (2001) 3.02
Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology (2001) 2.85
Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol (1992) 2.79
Heterogeneity of mitotic activity in breast cancer. Histopathology (1996) 2.77
Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). J Pathol (2005) 2.70
An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol (1994) 2.67
Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus. Oncogene (2006) 2.56
Comparison of 30-day, 90-day and in-hospital postoperative mortality for eight different cancer types. Br J Surg (2012) 2.44
Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant. J Am Coll Surg (1997) 2.43
Mortality and morbidity of planned relaparotomy versus relaparotomy on demand for secondary peritonitis. Br J Surg (2004) 2.42
Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. Ann Thorac Surg (2001) 2.41
Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res (1993) 2.39
Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut (1998) 2.38
K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res (1996) 2.29
Profound hemodilution: what is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human? Anesth Analg (1992) 2.24
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res (1998) 2.23
Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol (2001) 2.20
Treatment of bile duct lesions after laparoscopic cholecystectomy. Gut (1996) 2.12
Desmoid tumours in familial adenomatous polyposis. Gut (1994) 2.08
Meta-analysis of relaparotomy for secondary peritonitis. Br J Surg (2002) 2.02
[Carcinoid tumors: current insights in biochemical and endocrine aspects, diagnosis and treatment]. Ned Tijdschr Geneeskd (1992) 2.02
Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol (2006) 2.02
Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer (2004) 2.00
The value of morphometry to classic prognosticators in breast cancer. Cancer (1985) 2.00
Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia. Am J Gastroenterol (2012) 1.98
Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res (2001) 1.98
Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid. Am J Pathol (1993) 1.91
Relationships between vascularization and proliferation in invasive breast cancer. J Pathol (1999) 1.90
Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc (1997) 1.88
MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer (2009) 1.87
Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut (1993) 1.85
Molecular identification of latent precancers in histologically normal endometrium. Cancer Res (2001) 1.84
Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients. Br J Surg (1997) 1.84
The standard diagnostic work-up and surgical treatment of pancreatic head tumours. Eur J Surg Oncol (1999) 1.82
Colorectal neoplasia in juvenile polyposis or juvenile polyps. Arch Dis Child (1991) 1.81
Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol (1994) 1.79
[The registration of complications of medical treatment]. Ned Tijdschr Geneeskd (2003) 1.79
Diaphragmatic herniation following oesophagectomy. Br J Surg (1999) 1.78
Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut (2008) 1.77
Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med (1987) 1.76
Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest (1995) 1.75
Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection. Digestion (1989) 1.73
Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res (1998) 1.73
Leptin is a growth factor for colonic epithelial cells. Gastroenterology (2001) 1.71
Prospective evaluation of prognostic value of morphometry in patients with primary breast cancer. J Clin Pathol (1987) 1.71
Impaired quality of life 5 years after bile duct injury during laparoscopic cholecystectomy: a prospective analysis. Ann Surg (2001) 1.71
High resolution microarray comparative genomic hybridisation analysis using spotted oligonucleotides. J Clin Pathol (2004) 1.71
Diagnostic laparoscopy combined with laparoscopic ultrasonography in staging of cancer of the pancreatic head region. Br J Surg (1995) 1.70
Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol (2000) 1.69
Bacterial translocation in multiple organ failure: cause or epiphenomenon still unproven. Br J Surg (1997) 1.69
Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology (1997) 1.67
Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer (1995) 1.66
Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Br J Cancer (2002) 1.65
Intermethod variation in detection of human papillomavirus DNA in cervical smears. J Clin Microbiol (1995) 1.65
Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung. J Natl Cancer Inst (1991) 1.64
Readmissions after pancreatoduodenectomy. Br J Surg (2001) 1.64
Incidence and management of pancreatic leakage after pancreatoduodenectomy. Br J Surg (2005) 1.64
Surveillance in Barrett's oesophagus: a critical reappraisal. Scand J Gastroenterol Suppl (2002) 1.63
Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol (1998) 1.62
Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops. J Pathol (1998) 1.62
Microarray-based comparative genomic hybridization and its applications in human genetics. Clin Genet (2004) 1.61
Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy (2007) 1.60
Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac. Gut (1999) 1.59
Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol (1994) 1.59
[Hospital experience and hospital mortality following partial pancreaticoduodenectomy in The Netherlands]. Ned Tijdschr Geneeskd (1997) 1.58
Interlaboratory reproducibility of semiautomated cell cycle analysis of flow cytometry DNA-histograms obtained from fresh material of 1,295 breast cancer cases. Hum Pathol (1996) 1.58
Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. J Pathol (1998) 1.58
The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region. J Pathol (1998) 1.56
Comparative genomic hybridisation. Mol Pathol (1999) 1.56
Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma--a single center experience. Surgery (2000) 1.55
Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol (1998) 1.54
Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am J Pathol (1997) 1.54
There is no increased risk for colorectal cancer and adenomas in patients with diverticulitis: a retrospective longitudinal study. Colorectal Dis (2010) 1.53
Delayed gastric emptying after standard pancreaticoduodenectomy versus pylorus-preserving pancreaticoduodenectomy: an analysis of 200 consecutive patients. J Am Coll Surg (1997) 1.52
Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy (1999) 1.51
Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer (1999) 1.50
Rapid quantitative assessment of gastric corpus atrophy in tissue sections. J Clin Pathol (2001) 1.50
The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg (2000) 1.48